Pharmacy Podcast Network

By Pharmacy Podcast NetworkNews Medicine Health & Fitness Education Business News

Favorites
83
Followers
Typical duration
44 min
per episode

Based on Podcast App listening data

Pharmacy Podcast Network episodes

January 29, 2021 Pharmacy CrossRoads | Pharmacy Owner Richard Ost RPh
Today's special guest is Pharmacy owner & Community Champion Mr. Rich Ost, R.Ph., owner of Philadelphia Pharmacy located in Philadelphia, PA.
Philadelphia Pharmacy is a well-known and respected establishment in downtown Philadelphia. It has been located on the corner of N. Front St. and E. Leigh for nearly 40 years and is owned by Richard Ost, RPh. In a city famous for buildings painted with colorful mural, the pharmacy boasts one of the city’s most notable. The corner locations is wrapped in a 3 story tall mural, on both the store front and side of the building that colorfully represents the evolution of medicine from botanicals to modern day prescriptions.
In this episode of Pharmacy CrossRoads Ost tells Bruce Kneeland how, on Oct. 27, 2020, social unrest and rioting resulted in the looting of his pharmacy and several others in the City. Ost tells how, with the help of his staff, the community and suppliers the pharmacy was completely put back together and in a matter of days was once again serving the community. Ost also provides some words of advice for pharmacy owners on how they can prepare for this type of thing.
Ost also share some tips on how he and his team, over the past years have worked to earn the trust, support and patronage of the community. He says it takes time, creativity and building relationships of trust best earned by treating people with respect, adjusting to ethnic needs and simply providing people with top notch care.
Thank you to CPA the Compliant Pharmacy Alliance Cooperative for sponsoring the Pharmacy CrossRoads Podcast.
CPA is proud to serve independent pharmacy owners. For over 25 years, we have made your business, our business. With over 2,000+ member pharmacies, CPA leverages an exceptional membership and our expertise to obtain market leading economics, services, and support. Being a 100% member-owned cooperative, there are no conflicts of interest.
Learn more:
https://members.compliantrx.com/
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices
38 min
January 29, 2021 Pharmacy CrossRoads | Pharmacy Owner Richard Ost RPh
Today's special guest is Pharmacy owner & Community Champion Mr. Rich Ost, R.Ph., owner of Philadelphia Pharmacy located in Philadelphia, PA.
Philadelphia Pharmacy is a well-known and respected establishment in downtown Philadelphia. It has been located on the corner of N. Front St. and E. Leigh for nearly 40 years and is owned by Richard Ost, RPh. In a city famous for buildings painted with colorful mural, the pharmacy boasts one of the city’s most notable. The corner locations is wrapped in a 3 story tall mural, on both the store front and side of the building that colorfully represents the evolution of medicine from botanicals to modern day prescriptions.
In this episode of Pharmacy CrossRoads Ost tells Bruce Kneeland how, on Oct. 27, 2020, social unrest and rioting resulted in the looting of his pharmacy and several others in the City. Ost tells how, with the help of his staff, the community and suppliers the pharmacy was completely put back together and in a matter of days was once again serving the community. Ost also provides some words of advice for pharmacy owners on how they can prepare for this type of thing.
Ost also share some tips on how he and his team, over the past years have worked to earn the trust, support and patronage of the community. He says it takes time, creativity and building relationships of trust best earned by treating people with respect, adjusting to ethnic needs and simply providing people with top notch care.
Thank you to CPA the Compliant Pharmacy Alliance Cooperative for sponsoring the Pharmacy CrossRoads Podcast.
CPA is proud to serve independent pharmacy owners. For over 25 years, we have made your business, our business. With over 2,000+ member pharmacies, CPA leverages an exceptional membership and our expertise to obtain market leading economics, services, and support. Being a 100% member-owned cooperative, there are no conflicts of interest.
Learn more:
https://members.compliantrx.com/
See omnystudio.com/listener for privacy information.
38 min
January 28, 2021 Data Science & A.I. | FutureDose Tech
In the future data science and artificial intelligence will be routinely used to give clinicians diagnostic recommendations; give scientists testable hypotheses they can confirm experimentally and offer them insights into safe and precise treatments; and give patients guidance on self-care, e.g., how to lead a healthy lifestyle and recognize disease early.
Marinka Zitnik, PhD is an Assistant Professor of Biomedical Informatics, Harvard Medical School. Before joining Harvard, Dr. Zitnik was a postdoctoral fellow in Computer Science at Stanford University and was involved in projects at Chan Zuckerberg Biohub. Listen in as David and Marinka explain some AI concepts such as encoding, decoding, and embedding as well as discuss algorithms that can predict drug-drug interactions and identify medications that may be good candidates to treat COVID-19.
See omnystudio.com/listener for privacy information.
49 min
January 28, 2021 Data Science & A.I. | FutureDose Tech
In the future data science and artificial intelligence will be routinely used to give clinicians diagnostic recommendations; give scientists testable hypotheses they can confirm experimentally and offer them insights into safe and precise treatments; and give patients guidance on self-care, e.g., how to lead a healthy lifestyle and recognize disease early.
Marinka Zitnik, PhD is an Assistant Professor of Biomedical Informatics, Harvard Medical School. Before joining Harvard, Dr. Zitnik was a postdoctoral fellow in Computer Science at Stanford University and was involved in projects at Chan Zuckerberg Biohub. Listen in as David and Marinka explain some AI concepts such as encoding, decoding, and embedding as well as discuss algorithms that can predict drug-drug interactions and identify medications that may be good candidates to treat COVID-19.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices
49 min
January 27, 2021 Mark Cuban’s Cost Plus Drugs w/ CEO Dr. Alex Oshmyansky, MD, PhD
The new podcast called “Decoder with Nilay Patel” episode 1 @reckless released on Nov 10, 2020 with special guest MARK CUBAN ON AMERICA’S FUTURE & a short clip about Cost Plus Drugs.
Alex Oshmyansky, MD, PhD is the CEO & Founder at Mark Cuban Cost Plus Drug Company.
Dr. Alex along with strategic investor & business mogul Mark Cuban has launched Mark Cuban Cost Plus Drug Company, a pharmaceutical company that plans to make less expensive versions of selected generic drugs. The company's first drug is a generic version of albendazole, an antiparasitic drug used to treat hookworm. Treated early, two tablets will treat the infection; left untreated, cognitive defects and neurological problems can result.
Cost Plus Drug Company is dedicated to producing low-cost versions of high-cost generic drugs.
In this interview, Dr. Alex pledges to provide radical transparency in how they price their drugs. Dr. Alex has committed letting everyone know what it costs to manufacture, distribute, and market drugs to pharmacies. They will add a flat 15% margin to get wholesale prices. This will help to ensure they remain viable and profitable. There are no hidden costs, no middlemen, no rebates only available to insurance companies. Everybody gets the same low price for every drug they make.
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices
27 min
January 27, 2021 Mark Cuban’s Cost Plus Drugs w/ CEO Dr. Alex Oshmyansky, MD, PhD
The new podcast called “Decoder with Nilay Patel” episode 1 @reckless released on Nov 10, 2020 with special guest MARK CUBAN ON AMERICA’S FUTURE & a short clip about Cost Plus Drugs.
Alex Oshmyansky, MD, PhD is the CEO & Founder at Mark Cuban Cost Plus Drug Company.
Dr. Alex along with strategic investor & business mogul Mark Cuban has launched Mark Cuban Cost Plus Drug Company, a pharmaceutical company that plans to make less expensive versions of selected generic drugs. The company's first drug is a generic version of albendazole, an antiparasitic drug used to treat hookworm. Treated early, two tablets will treat the infection; left untreated, cognitive defects and neurological problems can result.
Cost Plus Drug Company is dedicated to producing low-cost versions of high-cost generic drugs.
In this interview, Dr. Alex pledges to provide radical transparency in how they price their drugs. Dr. Alex has committed letting everyone know what it costs to manufacture, distribute, and market drugs to pharmacies. They will add a flat 15% margin to get wholesale prices. This will help to ensure they remain viable and profitable. There are no hidden costs, no middlemen, no rebates only available to insurance companies. Everybody gets the same low price for every drug they make.
See omnystudio.com/listener for privacy information.
27 min
January 26, 2021 A Mother's Strength & Resilience of a Daughter w/ Brain Cancer | Team Livi
Special Episode:
A Mother's Strength & Resilience of a Daughter w/ Brain Cancer | Team Livi
Todd Eury here, founder of the Pharmacy Podcast Network, with a first for our listeners since launching in 2009, I interview the most important person in healthcare, our patient. The mother of a little 10 year old girl, Livi, who has brain cancer.
Livi's mother is Shannon Sealy, from my home town, Brownsville Pennsylvania.
Help Livi Beat Brain Cancer
CLICK HERE TO DONATE:
https://www.gofundme.com/f/help-livi-beat-brain-cancer?rcid=bae1ad4959be44a795bf8566e381dc7a&utm_campaign=p_na+share-sheet&utm_medium=copy_link&utm_source=customer
Data from this episode:
Corticosteroids in brain cancer patients: benefits and pitfalls
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109638/
Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood:
https://pubmed.ncbi.nlm.nih.gov/8487049/
See omnystudio.com/listener for privacy information.
40 min
January 26, 2021 A Mother’s Strength & Resilience of a Daughter w/ Brain Cancer | Team Livi
Special Episode:
A Mother's Strength & Resilience of a Daughter w/ Brain Cancer | Team Livi
Todd Eury here, founder of the Pharmacy Podcast Network, with a first for our listeners since launching in 2009, I interview the most important person in healthcare, our patient. The mother of a little 10 year old girl, Livi, who has brain cancer.
Livi's mother is Shannon Sealy, from my home town, Brownsville Pennsylvania.
Help Livi Beat Brain Cancer
CLICK HERE TO DONATE:
https://www.gofundme.com/f/help-livi-beat-brain-cancer?rcid=bae1ad4959be44a795bf8566e381dc7a&utm_campaign=p_na+share-sheet&utm_medium=copy_link&utm_source=customer
Data from this episode:
Corticosteroids in brain cancer patients: benefits and pitfalls
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109638/
Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood:
https://pubmed.ncbi.nlm.nih.gov/8487049/
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices
40 min
January 26, 2021 Closer to the Heart | GameChangers
In December 2020, the American College of Cardiology published an Expert Consensus Decision Pathway for Antithrombotic Therapy in Patients undergoing Percutaneous Coronary Intervention. This guideline addresses a timely problem of patients on anticoagulation and antiplatelet therapy.
This episode is accredited for CPE. Subscribe at CEimpact ( https://www.ceimpact.com/pharmacist ) and claim your CE today!
Reference: 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. Dec 18, 2020. Epublished DOI: 10.1016/j.jacc.2020.09.011. Accessed at https://www.jacc.org/doi/10.1016/j.jacc.2020.09.011
CPE details for GameChangers Podcast January 2021
Learning Objective: Recommend an appropriate antithrombotic/anticoagulant regimen in a patient who has received percutaneous coronary intervention with stenting
0107-0000-21-079-H01-P
0.2 CEU/2.0 Hrs (Knowledge)
Initial Release Date: 01/25/21
Expiration Date: 01/26/24
Additional CPE information is located at https://www.ceimpact.com/podcast
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices
28 min
January 26, 2021 Closer to the Heart | GameChangers
In December 2020, the American College of Cardiology published an Expert Consensus Decision Pathway for Antithrombotic Therapy in Patients undergoing Percutaneous Coronary Intervention. This guideline addresses a timely problem of patients on anticoagulation and antiplatelet therapy.
This episode is accredited for CPE. Subscribe at CEimpact ( https://www.ceimpact.com/pharmacist ) and claim your CE today!
Reference: 2020 ACC Expert Consensus Decision Pathway for Anticoagulant and Antiplatelet Therapy in Patients With Atrial Fibrillation or Venous Thromboembolism Undergoing Percutaneous Coronary Intervention or With Atherosclerotic Cardiovascular Disease: A Report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. Dec 18, 2020. Epublished DOI: 10.1016/j.jacc.2020.09.011. Accessed at https://www.jacc.org/doi/10.1016/j.jacc.2020.09.011
CPE details for GameChangers Podcast January 2021
Learning Objective: Recommend an appropriate antithrombotic/anticoagulant regimen in a patient who has received percutaneous coronary intervention with stenting
0107-0000-21-079-H01-P
0.2 CEU/2.0 Hrs (Knowledge)
Initial Release Date: 01/25/21
Expiration Date: 01/26/24
Additional CPE information is located at https://www.ceimpact.com/podcast
See omnystudio.com/listener for privacy information.
28 min

About Pharmacy Podcast Network

From the publisher's feed

Pharmacy Podcast Network (PPN) is the world’s largest network of podcasts dedicated to the pharmacy professional and industry insiders. Our content is about dynamic people in the pharmacy industry making a difference and delivering the best pharmacy care. We have over 40+ podcasts with thousands of interviews.

Pharmacists are the cornerstone of healthcare, and the PPN reflects that. From Community, LTC, Specialty Pharmacy to Drug Development, Government policy and DigitalHealth, we cover it all. Partner with us to connect with thousands of daily listeners and find the right pharmacist across various specialties and topics, ensuring your products and services resonate where it matters most. We build strong audio brands through Pharmacists who see patients almost 9x more than primary care.